<p>Subscribe at <a href="biotechblueprint.com" target="_blank" rel="noopener noreferer">biotechblueprint.com</a>. </p>

<p>Subscribe at <a href="biotechblueprint.com" rel="noopener noreferrer">biotechblueprint.com</a>. </p>

Trump cuts IVF & Medicaid drug prices; Novo buys Omeros; Lilly's GLP-1 orforglipron shines — This Week in Biotech #74

Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.

For more content, please subscribe to biotechblueprint.substack.com.

Technology

Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs. For more content, please subscribe to biotechblueprint.substack.com.

Share Trump cuts IVF & Medicaid drug prices; Novo buys Omeros; Lilly's GLP-1 orforglipron shines — This Week in Biotech #74

Sign up to save your podcasts

Trump cuts IVF & Medicaid drug prices; Novo buys Omeros; Lilly's GLP-1 orforglipron shines — This Week in Biotech #74

Trump cuts IVF & Medicaid drug prices; Novo buys Omeros; Lilly's GLP-1 orforglipron shines — This Week in Biotech #74